Target intelligence / Profile preview

ATPase phospholipid transporting 8B4 (ATP8B4)

Target
ATP8B4
Molecular classification
Enzyme, Transporter, P-type ATPase, P4-ATPase family
01

Overview

ATPase phospholipid transporting 8B4 (ATP8B4) is a transmembrane enzyme and transporter belonging to the P4-ATPase family (type IV P-type ATPases). It uses ATP hydrolysis to catalyze the translocation ("flipping") of aminophospholipids from the outer to the inner leaflet of biological membranes, which is crucial for maintaining lipid asymmetry. This process is involved in essential cellular functions such as vesicle formation, signal transduction, and uptake of lipid signaling molecules. ATP8B4 is encoded on the human genome and has alternative splice variants. Dysfunction may be associated with intellectual disability and hepatic cholestasis. ATP8B4 functions as part of a larger flippase complex and interacts with accessory proteins for proper folding and activity. The substrate specificity of ATP8B4 is assumed similar to other ATP8B subfamily members (likely prefers phosphatidylcholine, but exact specificity awaits detailed biochemical confirmation).

Other names
Probable phospholipid-transporting ATPase IMATP8B4KIAA1939ATPIMATPase class I type 8B member 4P4-ATPase flippase complex alpha subunit ATP8B4putative phospholipid-transporting ATPase IM
02

Mechanism of action

For related P4-ATPases, inhibition disrupts phospholipid flipping, leading to altered membrane asymmetry and cell function. Specific mechanisms for ATP8B4-modulating drugs are not described

03

Biological functions

Maintenance of membrane lipid asymmetryPhospholipid transport (specifically flipping aminophospholipids like phosphatidylserine (PS) and potentially phosphatidylcholine (PC))Vesicle formationUptake of lipid signaling moleculesRegulation of cell membrane compositionPossibly involvement in innate immune system pathways
04

Disease associations

Intellectual developmental disorder, X-linked 109Benign recurrent intrahepatic cholestasisPotential roles in hepatic disorders and possibly other disorders related to phospholipid transport
05

Safety considerations

Defective ATP8B4 function may contribute to hepatic and neurological disorders, similar to related P4-ATPases. Direct safety concerns for targeted therapies are not established due to lack of therapeutics
06

Biomarkers

Externalization of phosphatidylserine as a cellular biomarker (in contexts of P4-ATPase dysfunction)

Beyond the preview

Go deeper on ATPase phospholipid transporting 8B4 (ATP8B4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATPase phospholipid transporting 8B4 (ATP8B4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call